0.424 per share or 80 % of the price we sell our common stock in a future “ qualified offering ” ; ( d ) 875,000 shares of our common stock owned by owp ventures prior to the merger were cancelled ; and ( e ) owp ventures ' chief operating officer became our chief operating officer and two of owp ventures ' directors became members of our board of directors . owp ventures , inc. is a holding company formed in delaware on march 27 , 2018 to enter and support the cannabis industry , and on may 30 , 2018 , it acquired one world pharma s.a.s . one world pharma s.a.s , is a licensed cannabis cultivation , production and distribution ( export ) company located in popayán , colombia ( nearest major city is cali ) . we plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe . we have received licenses to cultivate , produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal , scientific and industrial purposes . specifically , we are one of the only companies in colombia to receive seed , cultivation , extraction and export licenses from the colombian government . currently , we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp . in addition , we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members , under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques , and sell their harvested products to us on an exclusive basis . we planted our first crop of cannabis in 2018 , which we began harvesting in the first quarter of 2019 for the purpose of further research and development activities and quality control testing of the cannabis we have produced . we consummated our first sales and revenue beginning in the second quarter of 2020 with initial sales of fully registered non-psychoactive seeds . the merger was accounted for as a reverse merger ( recapitalization ) with owp ventures deemed to be the accounting acquirer . accordingly , the financial statements included in this 10-k and the following discussion reflect the historical operations of owp ventures and its wholly-owned subsidiary one world pharma s.a.s prior to the merger , and that of the combined company following the merger . the historical financial information for one world pharma , inc. ( formerly punto group corp. ) prior to the merger has been omitted . critical accounting policies the establishment and consistent application of accounting policies is a vital component of accurately and fairly presenting our financial statements in accordance with generally accepted accounting principles in the united states ( “ gaap ” ) , as well as ensuring compliance with applicable laws and regulations governing financial reporting . while there are rarely alternative methods or rules from which to select in establishing accounting and financial reporting policies , proper application often involves significant judgment regarding a given set of facts and circumstances and a complex series of decisions . 18 basis of presentation the accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the united states of america and the rules of the securities and exchange commission ( “ sec ” ) . all references to generally accepted accounting principles ( “ gaap ” ) are in accordance with the fasb accounting standards codification ( “ asc ” ) and the hierarchy of generally accepted accounting principles . these statements reflect all adjustments , consisting of normal recurring adjustments , which in the opinion of management are necessary for fair presentation of the information contained therein . principles of consolidation the accompanying consolidated financial statements include the accounts of the following entities , all of which were under common control and ownership at december 31 , 2020 : state of name of entity incorporation relationship one world pharma , inc. ( 1 ) nevada parent owp ventures , inc. ( 2 ) delaware subsidiary one world pharma s.a.s . ( 3 ) colombia subsidiary colombian hope , s.a.s . ( 4 ) colombia subsidiary ( 1 ) holding company in the form of a corporation . ( 2 ) holding company in the form of a corporation and wholly-owned subsidiary of one world pharma , inc. ( 3 ) wholly-owned subsidiary of owp ventures , inc. since may 30 , 2018 , located in colombia and legally constituted as a simplified stock company registered in the chamber of commerce of bogotá on july 18 , 2017. its headquarters are located in bogotá . ( 4 ) wholly-owned subsidiary of owp ventures , inc. , acquired on november 19 , 2019 , located in colombia and legally constituted as a simplified stock company . this company has yet to incur any income or expenses . the consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above . the company 's headquarters are located in las vegas , nevada and substantially all of its production efforts are within popayán , colombia . foreign currency translation the functional currency of the company is columbian peso ( “ cop ” ) . the company has maintained its financial statements using the functional currency , and translated those financial statements to the us dollar throughout this report . monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates . story_separator_special_tag the measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty 's performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for non-performance . income taxes the company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered . the company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not . uncertain tax positions in accordance with asc 740 , “ income taxes ” ( “ asc 740 ” ) , the company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position . these standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return . these standards also provide guidance on de-recognition , classification , interest and penalties , accounting in interim periods , disclosure , and transition . various taxing authorities periodically audit the company 's income tax returns . these audits include questions regarding the company 's tax filing positions , including the timing and amount of deductions and the allocation of income to various tax jurisdictions . in evaluating the exposures connected with these various tax filing positions , including state and local taxes , the company records allowances for probable exposures . a number of years may elapse before a particular matter , for which an allowance has been established , is audited and fully resolved . the company has not yet undergone an examination by any taxing authorities . the assessment of the company 's tax position relies on the judgment of management to estimate the exposures associated with the company 's various filing positions . various taxing authorities periodically audit the company 's income tax returns . these audits include questions regarding the company 's tax filing positions , including the timing and amount of deductions and the allocation of income to various tax jurisdictions . in evaluating the exposures connected with these various tax filing positions , including state and local taxes , the company records allowances for probable exposures . a number of years may elapse before a particular matter , for which an allowance has been established , is audited and fully resolved . the company has not yet undergone an examination by any taxing authorities . 21 results of operations for the years ended december 31 , 2020 and 2019 the following table summarizes selected items from the statement of operations for the years ended december 31 , 2020 and 2019. replace_table_token_2_th revenues revenues for the year ended december 31 , 2020 were $ 59,568 , compared to no revenues during the year ended december 31 , 2019 , as sales commenced in 2020 . cost of goods sold cost of goods sold for the year ended december 31 , 2020 were $ 104,729 , compared to $ -0- during the year ended december 31 , 2019. cost of goods sold consists primarily of labor , depreciation and maintenance on cultivation and production equipment , and supplies consumed in our operations . general and administrative expenses general and administrative expenses for the year ended december 31 , 2020 were $ 3,960,791 , compared to $ 2,225,551 for the year ended december 31 , 2019 , an increase of $ 1,735,240 , or 78 % . the expenses for the current period consisted primarily of compensation expenses , office rent , and travel costs , including $ 2,581,933 of stock-based compensation , of which $ 1,100,000 , consisting of 2,000,000 shares , were issued as severance pay to our former ceo , and $ 275,000 , consisting of 500,000 shares of common stock , along with $ 1,206,933 of expense related to stock options that were voluntarily surrendered and cancelled at year-end was incurred in connection with the employment of isiah thomas as our new chief executive officer in june 2020. goodwill impairment goodwill impairment , for the year ended december 31 , 2020 was $ -0- , compared to $ 102,000 during the year ended december 31 , 2019 , a decreased expense of $ 102,000. professional fees professional fees for the year ended december 31 , 2020 were $ 3,878,006 , compared to $ 3,473,300 during the year ended 2019 , an increase of $ 404,706 , or 12 % . professional fees included non-cash stock-based compensation of $ 3,167,252 during the year ended december 31 , 2020 , compared to $ 1,727,492 during the year ended december 31 , 2019 , an increase of $ 1,439,760 , or 83 % . professional fees increased primarily due to increased stock-based compensation during the current period . 22 depreciation expense we had $ 33,610 of depreciation expense for the year ended december 31 , 2020 , compared to $ 19,668 of depreciation expense for the year ended december 31 , 2019 , an increase of $ 13,942 , or 71 % . depreciation expense increased during the current period as additional assets have been placed in service . other income ( expense ) other expenses , on a net basis , for the year ended december 31 , 2020 were $ 47,592 , compared to other expenses , on a net basis , of $ 386,665 for the year ended december 31 , 2019. other expense during the year ended december 31 , 2020 consisted of $ 47,592 of interest expense . other expenses consisted

liquidity and capital resources as of december 31 , 2020 , the company had current assets of $ 420,619 , consisting of cash of $ 28,920 , accounts receivable of $ 5,636 , inventory of $ 267,152 and other current assets of $ 118,911. the company 's current liabilities as of december 31 , 2020 were $ 1,702,437 , consisting of $ 734,554 of accounts payable , $ 550,535 of accrued expenses , $ 37,236 of dividends payable , $ 45,271 of current lease liabilities , and $ 334,841 of debts . the following table summarizes our total current assets , liabilities and working capital at december 31 , 2020 and 2019. replace_table_token_3_th the following table summarizes our cash flows during the years ended december 31 , 2020 and 2019 , respectively . replace_table_token_4_th the decrease in funds used in operating activities for the year ended december 31 , 2020 , compared to the year ended december 31 , 2019 , was primarily due to diminished operations in the current year due to the global effects of the covid-19 pandemic . the decrease in funds used in investing activities for the year ended december 31 , 2020 , compared to the year ended december 31 , 2019 , was due primarily to decreased purchases of fixed assets in the year ended december 31 , 2020. the decrease in funds provided by financing activities for the year ended december 31 , 2020 , compared to the year endeddecember 31 , 2019 , was due primarily to decreased proceeds from the sale of our securities during the year ended december 31 , 2020 .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources as of december 31 , 2020 , the company had current assets of $ 420,619 , consisting of cash of $ 28,920 , accounts receivable of $ 5,636 , inventory of $ 267,152 and other current assets of $ 118,911. the company 's current liabilities as of december 31 , 2020 were $ 1,702,437 , consisting of $ 734,554 of accounts payable , $ 550,535 of accrued expenses , $ 37,236 of dividends payable , $ 45,271 of current lease liabilities , and $ 334,841 of debts . the following table summarizes our total current assets , liabilities and working capital at december 31 , 2020 and 2019. replace_table_token_3_th the following table summarizes our cash flows during the years ended december 31 , 2020 and 2019 , respectively . replace_table_token_4_th the decrease in funds used in operating activities for the year ended december 31 , 2020 , compared to the year ended december 31 , 2019 , was primarily due to diminished operations in the current year due to the global effects of the covid-19 pandemic . the decrease in funds used in investing activities for the year ended december 31 , 2020 , compared to the year ended december 31 , 2019 , was due primarily to decreased purchases of fixed assets in the year ended december 31 , 2020. the decrease in funds provided by financing activities for the year ended december 31 , 2020 , compared to the year endeddecember 31 , 2019 , was due primarily to decreased proceeds from the sale of our securities during the year ended december 31 , 2020 .
```    
 Suspicious Activity Report : 0.424 per share or 80 % of the price we sell our common stock in a future “ qualified offering ” ; ( d ) 875,000 shares of our common stock owned by owp ventures prior to the merger were cancelled ; and ( e ) owp ventures ' chief operating officer became our chief operating officer and two of owp ventures ' directors became members of our board of directors . owp ventures , inc. is a holding company formed in delaware on march 27 , 2018 to enter and support the cannabis industry , and on may 30 , 2018 , it acquired one world pharma s.a.s . one world pharma s.a.s , is a licensed cannabis cultivation , production and distribution ( export ) company located in popayán , colombia ( nearest major city is cali ) . we plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe . we have received licenses to cultivate , produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal , scientific and industrial purposes . specifically , we are one of the only companies in colombia to receive seed , cultivation , extraction and export licenses from the colombian government . currently , we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp . in addition , we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members , under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques , and sell their harvested products to us on an exclusive basis . we planted our first crop of cannabis in 2018 , which we began harvesting in the first quarter of 2019 for the purpose of further research and development activities and quality control testing of the cannabis we have produced . we consummated our first sales and revenue beginning in the second quarter of 2020 with initial sales of fully registered non-psychoactive seeds . the merger was accounted for as a reverse merger ( recapitalization ) with owp ventures deemed to be the accounting acquirer . accordingly , the financial statements included in this 10-k and the following discussion reflect the historical operations of owp ventures and its wholly-owned subsidiary one world pharma s.a.s prior to the merger , and that of the combined company following the merger . the historical financial information for one world pharma , inc. ( formerly punto group corp. ) prior to the merger has been omitted . critical accounting policies the establishment and consistent application of accounting policies is a vital component of accurately and fairly presenting our financial statements in accordance with generally accepted accounting principles in the united states ( “ gaap ” ) , as well as ensuring compliance with applicable laws and regulations governing financial reporting . while there are rarely alternative methods or rules from which to select in establishing accounting and financial reporting policies , proper application often involves significant judgment regarding a given set of facts and circumstances and a complex series of decisions . 18 basis of presentation the accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the united states of america and the rules of the securities and exchange commission ( “ sec ” ) . all references to generally accepted accounting principles ( “ gaap ” ) are in accordance with the fasb accounting standards codification ( “ asc ” ) and the hierarchy of generally accepted accounting principles . these statements reflect all adjustments , consisting of normal recurring adjustments , which in the opinion of management are necessary for fair presentation of the information contained therein . principles of consolidation the accompanying consolidated financial statements include the accounts of the following entities , all of which were under common control and ownership at december 31 , 2020 : state of name of entity incorporation relationship one world pharma , inc. ( 1 ) nevada parent owp ventures , inc. ( 2 ) delaware subsidiary one world pharma s.a.s . ( 3 ) colombia subsidiary colombian hope , s.a.s . ( 4 ) colombia subsidiary ( 1 ) holding company in the form of a corporation . ( 2 ) holding company in the form of a corporation and wholly-owned subsidiary of one world pharma , inc. ( 3 ) wholly-owned subsidiary of owp ventures , inc. since may 30 , 2018 , located in colombia and legally constituted as a simplified stock company registered in the chamber of commerce of bogotá on july 18 , 2017. its headquarters are located in bogotá . ( 4 ) wholly-owned subsidiary of owp ventures , inc. , acquired on november 19 , 2019 , located in colombia and legally constituted as a simplified stock company . this company has yet to incur any income or expenses . the consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above . the company 's headquarters are located in las vegas , nevada and substantially all of its production efforts are within popayán , colombia . foreign currency translation the functional currency of the company is columbian peso ( “ cop ” ) . the company has maintained its financial statements using the functional currency , and translated those financial statements to the us dollar throughout this report . monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates . story_separator_special_tag the measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty 's performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for non-performance . income taxes the company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered . the company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not . uncertain tax positions in accordance with asc 740 , “ income taxes ” ( “ asc 740 ” ) , the company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position . these standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return . these standards also provide guidance on de-recognition , classification , interest and penalties , accounting in interim periods , disclosure , and transition . various taxing authorities periodically audit the company 's income tax returns . these audits include questions regarding the company 's tax filing positions , including the timing and amount of deductions and the allocation of income to various tax jurisdictions . in evaluating the exposures connected with these various tax filing positions , including state and local taxes , the company records allowances for probable exposures . a number of years may elapse before a particular matter , for which an allowance has been established , is audited and fully resolved . the company has not yet undergone an examination by any taxing authorities . the assessment of the company 's tax position relies on the judgment of management to estimate the exposures associated with the company 's various filing positions . various taxing authorities periodically audit the company 's income tax returns . these audits include questions regarding the company 's tax filing positions , including the timing and amount of deductions and the allocation of income to various tax jurisdictions . in evaluating the exposures connected with these various tax filing positions , including state and local taxes , the company records allowances for probable exposures . a number of years may elapse before a particular matter , for which an allowance has been established , is audited and fully resolved . the company has not yet undergone an examination by any taxing authorities . 21 results of operations for the years ended december 31 , 2020 and 2019 the following table summarizes selected items from the statement of operations for the years ended december 31 , 2020 and 2019. replace_table_token_2_th revenues revenues for the year ended december 31 , 2020 were $ 59,568 , compared to no revenues during the year ended december 31 , 2019 , as sales commenced in 2020 . cost of goods sold cost of goods sold for the year ended december 31 , 2020 were $ 104,729 , compared to $ -0- during the year ended december 31 , 2019. cost of goods sold consists primarily of labor , depreciation and maintenance on cultivation and production equipment , and supplies consumed in our operations . general and administrative expenses general and administrative expenses for the year ended december 31 , 2020 were $ 3,960,791 , compared to $ 2,225,551 for the year ended december 31 , 2019 , an increase of $ 1,735,240 , or 78 % . the expenses for the current period consisted primarily of compensation expenses , office rent , and travel costs , including $ 2,581,933 of stock-based compensation , of which $ 1,100,000 , consisting of 2,000,000 shares , were issued as severance pay to our former ceo , and $ 275,000 , consisting of 500,000 shares of common stock , along with $ 1,206,933 of expense related to stock options that were voluntarily surrendered and cancelled at year-end was incurred in connection with the employment of isiah thomas as our new chief executive officer in june 2020. goodwill impairment goodwill impairment , for the year ended december 31 , 2020 was $ -0- , compared to $ 102,000 during the year ended december 31 , 2019 , a decreased expense of $ 102,000. professional fees professional fees for the year ended december 31 , 2020 were $ 3,878,006 , compared to $ 3,473,300 during the year ended 2019 , an increase of $ 404,706 , or 12 % . professional fees included non-cash stock-based compensation of $ 3,167,252 during the year ended december 31 , 2020 , compared to $ 1,727,492 during the year ended december 31 , 2019 , an increase of $ 1,439,760 , or 83 % . professional fees increased primarily due to increased stock-based compensation during the current period . 22 depreciation expense we had $ 33,610 of depreciation expense for the year ended december 31 , 2020 , compared to $ 19,668 of depreciation expense for the year ended december 31 , 2019 , an increase of $ 13,942 , or 71 % . depreciation expense increased during the current period as additional assets have been placed in service . other income ( expense ) other expenses , on a net basis , for the year ended december 31 , 2020 were $ 47,592 , compared to other expenses , on a net basis , of $ 386,665 for the year ended december 31 , 2019. other expense during the year ended december 31 , 2020 consisted of $ 47,592 of interest expense . other expenses consisted

